BIOMARKER

Ed Rainger; Gerard Nash; Andrew Bradbury; Donald Adam; Mohamed Abdelhamid

BIOMARKER

Ed Rainger (Inventor), Gerard Nash (Inventor), Andrew Bradbury (Inventor), Donald Adam (Inventor), Mohamed Abdelhamid (Inventor)

Research output: Patent

Abstract

A method of diagnosing or determining the degree of an arterial aneurysm, especially an abdominal aortic aneurysm, which comprises determining the presence or level of interleukin-1α (IL-1aα) in a serum or plasma sample.

Original language	English
Patent number	WO/2011/141746
Publication status	Published - 17 Nov 2011

Cite this

@misc{e339e5acf7154016bf8cd3567acde471,

title = "BIOMARKER",

abstract = "A method of diagnosing or determining the degree of an arterial aneurysm, especially an abdominal aortic aneurysm, which comprises determining the presence or level of interleukin-1α (IL-1aα) in a serum or plasma sample.",

author = "Ed Rainger and Gerard Nash and Andrew Bradbury and Donald Adam and Mohamed Abdelhamid",

year = "2011",

month = nov,

day = "17",

language = "English",

type = "Patent",

note = "WO/2011/141746",

}

TY - PAT

T1 - BIOMARKER

AU - Rainger, Ed

AU - Nash, Gerard

AU - Bradbury, Andrew

AU - Adam, Donald

AU - Abdelhamid, Mohamed

PY - 2011/11/17

Y1 - 2011/11/17

N2 - A method of diagnosing or determining the degree of an arterial aneurysm, especially an abdominal aortic aneurysm, which comprises determining the presence or level of interleukin-1α (IL-1aα) in a serum or plasma sample.

AB - A method of diagnosing or determining the degree of an arterial aneurysm, especially an abdominal aortic aneurysm, which comprises determining the presence or level of interleukin-1α (IL-1aα) in a serum or plasma sample.

M3 - Patent

M1 - WO/2011/141746

ER -

BIOMARKER

Abstract

Fingerprint

Cite this